Hints and tips:
Related Special Reports
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...Schultz halts Starbucks buybacks Howard Schultz pledged to suspend Starbucks’ share buyback programme as he began his third term as the US coffee chain’s chief executive....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...Howard Njoo, Canada’s deputy chief public health officer, said the government would announce more details on allocation of the vaccine in the coming days....
...The aborted trials include Pfizer and Johnson & Johnson’s scrapped study in 2012 and Merck’s failed trial in 2017....
...The BioNTech/Pfizer and Moderna shots use messenger RNA technology....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...They believe that before the end of the year we could see vaccines from Pfizer and their German partner BioNTech, and AstraZeneca and Oxford university....
..., a fund he co-founded alongside Alan Howard and three others....
...Disappointed, Pfizer pulled out of neuroscience research last year....
...Yet as Starbucks’ Howard Schultz knows all too well, it’s quite possible to mis-step when you take a stand....
...But the Welsh actor Rhys Ifans swears by it, as did his fellow Welshman the late Howard Marks....
...To take a recent example, ticket sales for Batman v Superman: Dawn of Justice dropped by an astonishing 68.4 per cent on its second weekend, as comic-book fans returned to their dens....
...Like the chief executive, many of the top brass hailed from McKinsey , while Howard Schiller, chief financial officer from 2011 until last summer, spent 25 years as an investment banker at Goldman Sachs....
...Pfizer, United Technologies, Procter & Gamble, Microsoft and Google have been among the long list of multinationals that have blamed the US greenback for lost sales....
...Pyramid scheme Asked whether he could see anything on peering into Tutankhamun’s tomb, Howard Carter breathlessly replied: “Yes! Wonderful things!”...
...The possibility of a Pfizer/AstraZeneca deal still has the politicians talking (the chief executives of both were hauled before the UK parliament this week)....
...The tally would be pushed to record levels if Pfizer presses ahead with a firm bid for AstraZeneca having had an informal £60bn offer rebuffed by the UK company....
...“The Wyeth/Pfizer business would in some ways be a perfect strategic fit for Heinz because it is so focused in emerging markets,” Alexia Howard, analyst at Bernstein Research, said last month....
...beyondbrics India v China: a new race in biopharmaceuticals, beyondbrics...
...less than five months for what Time Inc colleagues described as an abrasive management style....
...Mr Vernon, who is the ‘v’ in Brevan, intends to “pursue other interests”. Of the five founding partners, Jean-Philippe Blochet left in November 2009 to join Moore Capital....
...Deal activity and changes at the top of Pfizer and Kellogg failed to stop US stocks following global markets slightly lower....
...Companies such as GlaxoSmithKline have restructured and slimmed down their research arms but the sector remains troubled, as the departure of Jeff Kindler, Pfizer’s former chief executive, on the grounds...
International Edition